Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN116178386B reveals high-purity LE14 synthesis. Reduces impurities and costs for ADC manufacturing supply chains globally.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Patent CN116178153A discloses novel monodentate phosphine ligands enabling high-yield, high-ee palladium-catalyzed Tsuji-Trost reactions for cost-effective pharmaceutical intermediate manufacturing.
Patent CN110590597A details mild synthesis of aryl triazene. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN114716356A details a green Rh-catalyzed route for isothiocyanates, offering safer alternatives to thiophosgene and improved supply chain reliability for fine chemical manufacturing.
Patent CN111518131A details a novel high-yield synthesis for Orlistat intermediates, offering significant cost reduction and superior purity for pharmaceutical manufacturing supply chains.
Patent CN113912515A reveals a novel crystallization method for high-purity sartan biphenyl, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Novel low-valent titanium route replaces Grignard. High purity 99.9%, scalable process for antihistamine API manufacturing.
Patent CN108440542B details asymmetric synthesis of spiro oxindoles. High purity and mild conditions offer cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106589017B details a water-based synthesis for 3',4',7-trihydroxyethyl rutin. This method reduces waste and offers significant cost advantages for pharmaceutical intermediates manufacturing supply chains.
Novel solvent-based method for Glimepiride intermediate ensures high purity and safe commercial scale-up reducing genotoxic impurity risks for pharmaceutical supply chains globally
Discover the patented supercritical ammonia synthesis route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane. Enhance purity and reduce solvent costs for antiviral intermediates.
Novel bromide salt method reduces toxicity and cost. Reliable supply chain for high-purity intermediates. Scalable industrial process.
Advanced synthesis of Simeprevir intermediate via patent CN105348144B offers high purity and safer manufacturing for global pharmaceutical supply chains.
Patent CN108947819A reveals Pd-catalyzed deuteration. High purity over 98 percent, cost-effective solvent system for reliable supply chain.
Patent CN105348144B details a high-purity synthetic route for Simeprevir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced synthesis of 3-(7-amidino-2-naphthyl) derivatives via amidoxime reduction. Superior optical purity and scalable manufacturing for reliable API intermediate supply.
Patent CN106567104A reveals a green electrochemical route for 1,1'-diindolylmethane derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel copper-catalyzed oxidative cyclization method for 3-formyl-imidazo[1,2-a]pyridine. Reduces steps and improves yield for pharmaceutical intermediates.
Patent CN107721920B details a novel Rh(III)-catalyzed C(sp3)-H amidation. Offers high atom economy and mild conditions for pharmaceutical intermediate manufacturing.